World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
77
Citations
18526
World Ranking
1845
National Ranking
73

Medicine

D-Index
77
Citations
18526
World Ranking
18542
National Ranking
616

Rajiv Khanna publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rajiv Khanna sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 283 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rajiv Khanna D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rajiv Khanna sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Rajiv Khanna is affiliated with the QIMR Berghofer Medical Research Institute in Australia. Their research spans primarily in the field of Medicine, with a focus on several subfields including Oncology, Infectious Diseases, Immunology, Epidemiology, and Molecular Biology.

Their recent publications highlight an emphasis on immunology and infectious disease research, often intersecting with cancer studies and viral infections. Notable papers include:

  • CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses (2021, Immunity)
  • Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation? (2020, International Journal of Cancer)
  • Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity (2020, Journal of Virology)
  • Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme (2020, Journal of Clinical Investigation)
  • Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients (2020, The Journal of Experimental Medicine)

Their frequent co-authors include Corey Smith, Michelle A. Neller, Pauline Crooks, Archana Panikkar, and George Ambalathingal, with collaborations ranging from 20 to 39 coauthored papers.

Rajiv Khanna's work has been published across multiple venues with several recurring publication venues such as:

  • Cytotherapy (12 publications)
  • Clinical & Translational Immunology (7 publications)
  • arXiv (Cornell University) (6 publications)
  • Nature Communications (3 publications)
  • The Journal of Experimental Medicine (2 publications)

The main research topics covered by their work include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • CAR-T cell therapy research
  • Polyomavirus and related diseases
  • Immunotherapy and Immune Responses
  • Viral-associated cancers and disorders
  • Immune Cell Function and Interaction

Best Publications

  • Immunobiology of Human Cytomegalovirus: from Bench to Bedside

    Tania Crough;Rajiv Khanna

  • Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments

    Maher K Gandhi;Rajiv Khanna

  • Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

    R Khanna;S R Burrows;M G Kurilla;C A Jacob

  • Herpesvirus-Specific CD8 T Cell Immunity in Old Age: Cytomegalovirus Impairs the Response to a Coresident EBV Infection

    Naeem Khan;Andrew Hislop;Nancy Gudgeon;Mark Cobbold

  • Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers

    Rebecca Elkington;Susan Walker;Tania Crough;Moira Menzies

  • Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease

    Rajiv Khanna;Scott Bell;Martina Sherritt;Andrew Galbraith

  • An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.

    S R Burrows;R Khanna;J M Burrows;D J Moss

  • HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide Loading

    Chen Au Peh;Scott R Burrows;Megan Barnden;Rajiv Khanna

  • Immune regulation in Epstein-Barr virus-associated diseases.

    R Khanna;S R Burrows;D J Moss

  • Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

    Maher K. Gandhi;Eleanore Lambley;Eleanore Lambley;Eleanore Lambley;Jaikumar Duraiswamy;Jaikumar Duraiswamy;Jaikumar Duraiswamy;Ujjwal Dua;Ujjwal Dua;Ujjwal Dua

  • G-quadruplexes regulate Epstein-Barr virus–encoded nuclear antigen 1 mRNA translation

    Pierre Murat;Jie Zhong;Lea Lekieffre;Nathan P Cowieson

  • Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expression

    Martin Rowe;Rajiv Khanna;Catherine A. Jacob;Victor Argaet

  • Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated Diseases

    Rajiv Khanna;Scott R. Burrows

  • Identification of cytotoxic T cell epitopes within Epstein‐Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype‐restricted immune recognition of EBV‐infected cells by LMP1‐specific cytotoxic T lymphocytes

    Rajiv Khanna;Scott R. Burrows;John Nicholls;Leith M. Poulsen

  • Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

    Amit Bar-Or;Michael P. Pender;Rajiv Khanna;Lawrence Steinman

  • BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies

    George R. Ambalathingal;George R. Ambalathingal;Ross S. Francis;Ross S. Francis;Mark J. Smyth;Mark J. Smyth;Corey Smith

  • Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivity

    Scott R. Burrows;Sharon L. Silins;Rajiv Khanna;Jacqueline M. Burrows

  • Epstein–Barr virus-associated Hodgkin's lymphoma

    Maher K. Gandhi;Judy T. Tellam;Rajiv Khanna

  • Autologous T cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

    Andrea Schuessler;Corey Smith;Leone Beagley;Glen M Boyle

  • T Cell Receptor Repertoire for a Viral Epitope in Humans Is Diversified by Tolerance to a Background Major Histocompatibility Complex Antigen

    S R Burrows;S L Silins;D J Moss;R Khanna

Frequent Co-Authors

Scott R. Burrows
Scott R. Burrows QIMR Berghofer Medical Research Institute
Denis J. Moss
Denis J. Moss QIMR Berghofer Medical Research Institute
John J. Miles
John J. Miles James Cook University
Maher K. Gandhi
Maher K. Gandhi University of Queensland
Jamie Rossjohn
Jamie Rossjohn Monash University
Michael P. Pender
Michael P. Pender University of Queensland
James McCluskey
James McCluskey University of Melbourne
Scott C. Bell
Scott C. Bell University of Queensland
Stephanie Gras
Stephanie Gras La Trobe University
John M. Nicholls
John M. Nicholls University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to various healthcare careers that often require complementary education credentials. Many students exploring this field opt for accelerated programs that allow quick entry or advancement in the healthcare workforce. For instance, students interested in nursing can consider the easiest absn to get into, which provides a faster path to becoming a registered nurse while balancing prior education and experience.

Similarly, for those aiming to start their clinical careers sooner, exploring easy lpn programs to get into offers a practical option with shorter timelines and flexible formats. As healthcare demands grow, advancing further through online programs is possible. The easiest online nurse practitioner programs can provide a seamless transition to higher responsibility roles in patient care.

For professionals interested in mental health specialties, enrolling in top pmhnp programs ensures strong clinical placements and hands-on experience, essential for successful careers in psychiatric mental health nursing. Overall, combining immunology knowledge with these related degrees enhances career flexibility and growth in the dynamic healthcare landscape.

Best Scientists Citing Rajiv Khanna

Trending Scientists

Recently Published Articles